`Sent:
`To:
`Subject:
`
`kate dawson/cambridge/biogenidec;nsf;kate.dawson@biogenidec.com;smtp
`Thu Dec 21 2006 16:51:48 EST
`
`MRI minutes
`
`Here is how I editted. I have sent to
`
` for input - hope that is ok.
`
`
`
`Happy Holidays!
`
`Kate
`
`Page 1 of 3
`
`Biogen Exhibit 2211
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`Date: Monday. 18 December 2006
`
`
`
`
`
`
`
`Meeting Agenda:
`
`
`. The purpose of the discussion:
`0
`
`
`
`
`
`
`
`0
`Initiate discussion between the two contracted Central MRI Reading Centers for the BGOOOI2 Phase 3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Program. Protocol #L l09MS30l and 109MS302
`
`
`
`
`
`Discuss and document how the MRI Reading Centers plan to conduct the analysis of the MRI Data
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(i.e.._ lesion and Volume counts, etc) and,
`
`
`
`
`
`
`
`Ensure data analysis as consistent as possible across both the Reading Centers and studies
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Meeting Attendees:
`
`
`Bio en Idec
`DB :
`
`
`
`Kate Dawson. MD
`
`
`
`
`
`
`
`
`
`
`
`. Independent Contractor (piiniany liaison between- and Biogen Idec)
`Minhua Yang. Lead Biostatistician
`
`lO9MS30l Ccnlrzil Reading Center :
`
`g 109MS302 MR1 Central Reading Center}:
`
`Discussion Points:
`
`I
`
`
`Time points:
`
`
`0
`In a subset of subjects. MRI are being collected at Baseline. Week 48 (year 1) and Week 96 (year
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2).
`
`The FDA recently reviewed the protocol and provided cormnents to BBB: these cornnients may
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`lead to a protocol amendinent. BBB is evaluatin the conirnents. and these ma lead to chan es in the
`
`
`
`
`
`
`
`
`
`
`
`
`current MRI data plan
`
`
`
`
`
`
`
`
`
`
`Page 2 of 3
`
`
`
`
`
`Page 3 of 3Page 3 of 3
`
`Page 3 0f 3
`
`Page 3 of 3
`
`